Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney problems.
The global diphtheria treatment market is growing at a slow rate due to high effectiveness and efficiency of the vaccine, falling profitability of vaccine manufacture, side effects associated with vaccines such as type A immune reaction and allergies, variability in the efficacy of vaccines. Financial restraints such as falling returns on investment and the resultant exit of a number of players from vaccine manufacture will affect the future growth of vaccines.

The global Diphtheria Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Diphtheria Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diphtheria Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Diphtheria Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Diphtheria Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Taj Pharmaceuticals
Bharat Pharmaceuticals
GSK
Sanofi-Pasteur
Merck
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tetanus Immune Globulin
Tetanus Toxoid
Tetanus-Diphtheria
Diphtheria Toxoid
Pertussis

Segment by Application
Antitoxin
Antibiotics
Others